Workflow
Zuming Bean(003030)
icon
Search documents
祖名股份(003030) - 关于公司2024年度利润分配方案的公告
2025-04-24 15:02
证券代码:003030 证券简称:祖名股份 公告编号:2025-017 祖名豆制品股份有限公司 关于公司2024年度利润分配方案的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚 假记载、误导性陈述或重大遗漏。 祖名豆制品股份有限公司(以下简称"公司")于 2025 年 4 月 24 日召开了第 五届董事会第九次会议和第五届监事会第七次会议,审议通过了《关于公司 2024 年度利润分配方案的议案》,拟以实施权益分派股权登记日登记的总股本扣除回 购专用证券账户(以下简称"回购专户")上股份为分配基数,向全体股东每 10 股派发现金红利 1.50 元(含税),不送红股,不转增股本。本事项尚需提交公司 股东大会审议通过,现将具体事宜公告如下: 一、利润分配方案的基本情况 根据天健会计师事务所(特殊普通合伙)出具的"天健审〔2025〕7568 号"《祖 名豆制品股份有限公司 2024 年度审计报告》,公司 2024 年度实现归属于母公司 股东的净利润-25,136,060.31元(合并报表口径),母公司实现净利润25,718,031.31 元(母公司口径,下同),加上年初未分配利润 153,17 ...
祖名股份(003030) - 2024年度独立董事述职报告(丁志军)
2025-04-24 14:32
祖名豆制品股份有限公司 2024 年度独立董事述职报告 (丁志军) 本人作为祖名豆制品股份有限公司(以下简称"公司")的独立董事,严格按 照《公司法》《证券法》《中国证监会上市公司独立董事管理办法》《深圳证券交 易所股票上市规则》《深圳证券交易所上市公司自律监管指引第 1 号——主板上 市公司规范运作》及《公司章程》《公司独立董事工作制度》等规定,在 2024 年度任职期间,认真履行了独立董事的职责,积极、按时出席董事会和股东大会, 积极关注公司的经营业务及发展情况,充分发挥独立董事的作用,切实维护公司 和股东特别是中小股东的利益,现将 2024 年度的履职情况报告如下: 一、独立董事的基本情况 (一)基本情况 丁志军先生,1970 年 12 月出生,中国国籍,无境外永久居留权,本科学历。 1991 年 8 月至 1992 年,在浙江万龙企业集团公司(原萧山市乡镇企业总公司) 投资发展部工作;1992 年至 1994 年,受委派至深圳中丝实业有限公司工作;1994 年至 1997 年,受委派至萧山中丝发展公司工作;1997 年至 2000 年 11 月,在浙 江松青律师事务所实习、专职律师执业;2000 年 ...
祖名股份(003030) - 2024年度独立董事述职报告(赵新建)
2025-04-24 14:32
(二)独立性情况说明 本人具备担任上市公司独立董事的任职资格,未在公司担任除独立董事以外 的任何职务,也未在公司主要股东公司担任任何职务,与公司以及主要股东之间 不存在利害关系或其他可能妨碍其进行独立客观判断的关系,不存在影响独立董 事独立性的情况。本人符合《中国证监会上市公司独立董事管理办法》《深圳证 券交易所上市公司自律监管指引第 1 号——主板上市公司规范运作》中对独立性 的相关要求。 祖名豆制品股份有限公司 2024 年度独立董事述职报告 (赵新建) 本人作为祖名豆制品股份有限公司(以下简称"公司")的独立董事,严格按 照《公司法》《证券法》《中国证监会上市公司独立董事管理办法》《深圳证券交 易所股票上市规则》《深圳证券交易所上市公司自律监管指引第 1 号——主板上 市公司规范运作》及《公司章程》《公司独立董事工作制度》等规定,在 2024 年度任职期间,认真履行了独立董事的职责,积极、按时出席董事会和股东大会, 积极关注公司的经营业务及发展情况,充分发挥独立董事的作用,切实维护公司 和股东特别是中小股东的利益,现将 2024 年度的履职情况报告如下: 一、独立董事的基本情况 (一)基本情况 赵新建先 ...
祖名股份(003030) - 董事会对独立董事独立性评估的专项意见
2025-04-24 14:32
经核查独立董事于建平、赵新建、丁志军的任职经历以及签署的相关自查文 件,上述人员未在公司担任除独立董事以外的任何职务,也未在公司主要股东公 司担任任何职务,与公司以及主要股东之间不存在利害关系或其他可能妨碍其进 行独立客观判断的关系,不存在影响独立董事独立性的情况,符合《上市公司独 立董事管理办法》《深圳证券交易所上市公司自律监管指引第 1 号——主板上市 公司规范运作》中对独立董事独立性的相关要求。 祖名豆制品股份有限公司董事会 2025 年 4 月 25 日 祖名豆制品股份有限公司董事会 对独立董事独立性自查情况的专项报告 根据中国证券监督管理委员会《上市公司独立董事管理办法》、深圳证券交 易所《股票上市规则》《上市公司自律监管指引第 1 号——主板上市公司规范运 作》等要求,祖名豆制品股份有限公司(以下简称"公司")董事会,就公司在 任独立董事于建平、赵新建、丁志军的独立性情况进行评估并出具如下专项意见: ...
祖名股份(003030) - 2024年度独立董事述职报告(于建平)
2025-04-24 14:31
祖名豆制品股份有限公司 2024 年度独立董事述职报告 (于建平) 本人作为祖名豆制品股份有限公司(以下简称"公司")的独立董事,严格按 照《公司法》《证券法》《中国证监会上市公司独立董事管理办法》《深圳证券交 易所股票上市规则》《深圳证券交易所上市公司自律监管指引第 1 号——主板上 市公司规范运作》及《公司章程》《公司独立董事工作制度》等规定,在 2024 年度任职期间,认真履行了独立董事的职责,积极、按时出席董事会和股东大会, 积极关注公司的经营业务及发展情况,充分发挥独立董事的作用,切实维护公司 和股东特别是中小股东的利益,现将 2024 年度的履职情况报告如下: 一、独立董事的基本情况 (一)基本情况 于建平先生,1973 年 08 月出生,中国国籍,无境外永久居留权,本科学历, 高级会计师、注册会计师、注册税务师。曾任浙江耀信会计师事务所有限公司主 任会计师、管理合伙人;现任杭州初灵信息技术股份有限公司、本公司独立董事。 (二)独立性情况说明 本人具备担任上市公司独立董事的任职资格,未在公司担任除独立董事以外 的任何职务,也未在公司主要股东公司担任任何职务,与公司以及主要股东之间 不存在利害关系或 ...
祖名股份(003030) - 2025 Q1 - 季度财报
2025-04-24 14:05
Financial Performance - The company's revenue for Q1 2025 was CNY 444,646,396.49, representing a 16.71% increase compared to CNY 380,991,172.96 in the same period last year[4] - The net profit attributable to shareholders was a loss of CNY 5,913,908.68, a decrease of 160.93% from a profit of CNY 9,705,935.81 in the previous year[4] - The basic and diluted earnings per share both decreased by 162.50%, resulting in a loss of CNY 0.05 per share compared to a profit of CNY 0.08 per share last year[4] - The total comprehensive income attributable to the parent company was -5,913,908.68 CNY, compared to 9,705,935.81 CNY in the previous period[26] - The company experienced a total comprehensive loss of -9,472,393.00 CNY, compared to a gain of 6,915,363.06 CNY in the previous period[26] Cash Flow - The net cash flow from operating activities increased significantly by 567.25%, reaching CNY 31,820,989.33, compared to a negative cash flow of CNY 6,810,309.14 in the same period last year[4] - Cash inflow from operating activities totaled 531,395,803.71 CNY, while cash outflow was 499,574,814.38 CNY, resulting in a net cash inflow[27] - The company reported a net cash outflow from investing activities of -28,821,359.76 CNY, compared to -98,362,319.86 CNY in the previous period[27] - Cash inflow from financing activities was 319,000,000.00 CNY, an increase from 236,672,482.78 CNY in the previous period[27] - The net cash flow from financing activities was 15,661,327.07 CNY, down from 52,719,998.93 CNY in the previous period[27] - The ending cash and cash equivalents balance was 161,025,671.22 CNY, compared to 140,399,074.78 CNY at the end of the previous period[27] Assets and Liabilities - Total assets at the end of the reporting period were CNY 2,323,018,023.55, reflecting a 1.30% increase from CNY 2,293,186,396.38 at the end of the previous year[4] - Current liabilities decreased to ¥915,687,019.46 from ¥1,006,565,618.73, indicating a reduction of 9.1%[22] - Non-current liabilities rose to ¥398,133,794.62, up from ¥268,578,015.80, representing a growth of 48.3%[22] - The total equity attributable to shareholders decreased to ¥997,558,778.22 from ¥1,002,845,846.28, a decline of 0.5%[22] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 11,504[10] - The largest shareholder, Cai Zuming, holds 24.08% of the shares, while the second-largest shareholder, Hangzhou Xianpin Investment Co., Ltd., holds 14.14%[10] Stock Options and Incentives - The company has approved a stock option incentive plan for 2024, aimed at aligning employee interests with company performance[11] - The company granted 720,000 stock options to 41 incentive objects with an exercise price adjusted to 12.21 CNY per share on June 7, 2024[14] - The company completed the registration of the stock option incentive plan on June 19, 2024, confirming the total number of options granted[14] - The company approved the cancellation of 35,750 stock options due to unmet performance targets and 5,000 options from a departed employee on April 24, 2025[15] - The employee stock ownership plan was approved on May 10, 2024, with the first transfer of shares occurring at a price of 8.24 CNY per share[18] - The company’s stock option plan was publicly disclosed on May 11, 2024, with no objections received during the public notice period[12] Operational Insights - The company is experiencing a ramp-up in production capacity from new facilities in Yangzhou and Hebei, which is impacting current profitability[8] - The company has plans for market expansion and new product development, although specific details were not disclosed in the conference call[25] Expenses - Total operating costs amounted to ¥453,511,881.04, up 21.4% from ¥373,767,125.22 in the prior period[24] - Research and development expenses for the current period were ¥2,807,284.56, slightly up from ¥2,604,329.26 in the previous period[24] - The company reported a significant increase in sales expenses, which rose to ¥73,991,307.44 from ¥54,615,915.10, an increase of 35.6%[24] Accounts Receivable and Inventory - Accounts receivable increased to 184,251,506.27 CNY from 180,744,140.81 CNY, indicating a rise of about 2.8%[20] - The company’s inventory decreased from 117,483,459.20 CNY to 107,586,180.21 CNY, reflecting a reduction of about 8.0%[20] - The company’s other current assets increased to 48,402,821.42 CNY from 35,833,809.71 CNY, marking a growth of approximately 35.0%[20] - The total current assets as of March 31, 2025, were reported at 543,277,797.46 CNY, compared to 515,554,891.56 CNY at the beginning of the period, showing an increase of approximately 5.3%[20] Audit Information - The company did not conduct an audit for the first quarter report[28]
祖名股份(003030) - 2024 Q4 - 年度财报
2025-04-24 14:05
Financial Performance - The company's operating revenue for 2024 was approximately ¥1.66 billion, representing a 12.58% increase compared to ¥1.48 billion in 2023[21]. - The net profit attributable to shareholders was a loss of approximately ¥25.14 million in 2024, a decline of 162.12% from a profit of ¥40.46 million in 2023[21]. - The net cash flow from operating activities decreased by 39.44% to approximately ¥106.85 million in 2024, down from ¥176.45 million in 2023[21]. - The total assets at the end of 2024 were approximately ¥2.29 billion, reflecting a 13.22% increase from ¥2.03 billion at the end of 2023[21]. - The basic earnings per share for 2024 was -¥0.20, a decrease of 162.50% compared to ¥0.32 in 2023[21]. - The company reported a significant decline in the weighted average return on equity, which fell to -2.46% in 2024 from 3.87% in 2023[21]. - The company's total revenue for 2024 reached ¥1,664,401,664.91, representing a year-on-year increase of 12.58% from ¥1,478,381,743.34 in 2023[76]. - Fresh soybean products accounted for 66.95% of total revenue, with sales amounting to ¥1,114,257,483.18, reflecting a 14.06% increase compared to ¥976,868,297.85 in the previous year[76]. Business Operations - The company has not changed its main business since its listing, indicating stability in operations[20]. - The company is positioned in the "other agricultural and sideline food processing" industry, specifically in "tofu production," which has seen rapid growth due to increasing consumer demand for food safety and quality[30]. - The company has over 400 main products, including fresh soybean products, plant protein drinks, and leisure soybean products, focusing on health food development[38][40]. - The company operates through three main sales models: distribution, supermarket, and direct sales, with distribution being the primary model[48]. - The company has established a strong marketing network, covering major retail and restaurant chains, enhancing market penetration and response speed[62]. Market Expansion and Innovation - The company is actively expanding its market presence through collaborations with new retail platforms and restaurant chains[42]. - The company aims to increase soybean consumption in line with national health initiatives, contributing to the high-quality development of the soybean industry[34]. - The company is committed to innovation, establishing a reward system for innovation and focusing on product and technology development to enhance market competitiveness[45]. - The company has launched three low-purine products in May 2024, certified as low-purine foods with a total purine value ≤ 50[47]. - The company introduced a new product strategy focusing on organic and low-purine series to meet health-conscious consumer demands[47]. Risk Management and Compliance - The company emphasizes the importance of risk awareness regarding forward-looking statements in the report[4]. - The company will enhance risk management by establishing a comprehensive risk prevention system[121]. - The company has established comprehensive internal control systems to ensure accurate and timely financial reporting and compliance with legal requirements[138]. - There were no significant legal violations or related party fund occupation incidents during the reporting period[139]. - The company maintains independence in assets, personnel, finance, organization, and business from its controlling shareholders and related enterprises[141]. Corporate Governance - The financial report confirms that all board members attended the meeting to review the annual report, ensuring accountability[4]. - The board of directors consists of 9 members, including 3 independent directors, ensuring compliance with legal and regulatory requirements[135]. - The company has held 2 shareholder meetings during the reporting period, adhering to all relevant regulations and ensuring shareholder rights are protected[134]. - The company has a complete and independent financial accounting department and management system, ensuring independent financial decision-making[144]. - The company’s annual and temporary shareholder meetings had participation rates of 68.14% and 61.84%, respectively[148]. Environmental Management - The company has established a comprehensive environmental management system and has obtained ISO 14001 certification[196]. - The company adheres to strict pollution discharge standards, including wastewater, waste gas, and solid waste management[196]. - The company has implemented measures to prevent and reduce environmental pollution and damage[195]. - The company’s wastewater discharge complies with the Class III standards of the Comprehensive Wastewater Discharge Standard[196]. - The company has committed to continuous improvement in environmental management practices, enhancing its pollution prevention capabilities[200]. Employee and Remuneration Policies - The total remuneration for directors, supervisors, and senior management during the reporting period amounted to CNY 3.3325 million[168]. - The chairman, Cai Zuming, received a total pre-tax remuneration of CNY 600,000[168]. - The company has a profit distribution policy that emphasizes stable returns to investors while considering long-term sustainable development[181]. - The company’s employee training program includes onboarding for new hires and ongoing professional development for existing staff[179]. - The professional composition of employees includes 1,994 production staff, 1,447 sales personnel, and 68 technical staff[177].
祖名股份(003030) - 股票交易异常波动公告
2025-04-13 07:46
证券代码:003030 证券简称:祖名股份 公告编号:2025-013 祖名豆制品股份有限公司 股票交易异常波动公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚 假记载、误导性陈述或重大遗漏。 一、股票交易异常波动的情况介绍 祖名豆制品股份有限公司(以下简称"公司"或"本公司") 股票于2025年4月 9日、2025年4月10日、 2025年4月11日连续三个交易日收盘价格跌幅偏离值累 计达到21.29%,根据《深圳证券交易所交易规则》的相关规定,属于股票交易 异常波动情形。 二、公司关注并核实情况的说明 针对公司股票交易异常波动的情况,公司进行了自查,并向公司控股股东、 实际控制人就相关问题进行了核实,现就有关情况说明如下: 1、公司前期披露的信息不存在需要更正、补充之处; 2、公司未发现近期公共媒体报道了可能或已经对本公司股票交易价格产生 较大影响的未公开重大信息; 3、公司近期经营情况正常,内外部经营环境未发生重大变化; 4、公司、控股股东和实际控制人不存在关于公司的应披露而未披露的重大 事项,或处于筹划阶段的重大事项; 5、股票异常波动期间,公司控股股东、实际控制人不存在买卖公司 ...
祖名股份(003030) - 股票交易异常波动公告
2025-04-07 09:01
祖名豆制品股份有限公司 股票交易异常波动公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚 假记载、误导性陈述或重大遗漏。 证券代码:003030 证券简称:祖名股份 公告编号:2025-012 一、股票交易异常波动的情况介绍 祖名豆制品股份有限公司(以下简称"公司"或"本公司") 股票于2025年4月 7日一个交易日收盘价格涨幅偏离值达到20.82%,根据《深圳证券交易所交易规 则》的相关规定,属于股票交易异常波动情形。 二、公司关注并核实情况的说明 针对公司股票交易异常波动的情况,公司进行了自查,并向公司控股股东、 实际控制人就相关问题进行了核实,现就有关情况说明如下: 1、公司前期披露的信息不存在需要更正、补充之处; 2、公司未发现近期公共媒体报道了可能或已经对本公司股票交易价格产生 较大影响的未公开重大信息; 3、公司近期经营情况正常,内外部经营环境未发生重大变化; 4、公司、控股股东和实际控制人不存在关于公司的应披露而未披露的重大 事项,或处于筹划阶段的重大事项; 5、股票异常波动期间,公司控股股东、实际控制人不存在买卖公司股票的 情形; 6、公司不存在违反公平信息披露规定的其他 ...
祖名股份(003030) - 关于独立董事任期届满辞职的公告
2025-03-28 07:45
证券代码:003030 证券简称:祖名股份 公告编号:2025-011 祖名豆制品股份有限公司 关于独立董事任期届满辞职的公告 丁志军先生在担任公司独立董事期间恪尽职守、勤勉尽责。公司董事会对丁 志军先生在任职期间为公司发展做出的贡献表示衷心感谢! 特此公告。 祖名豆制品股份有限公司董事会 2025 年 3 月 29 日 | 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚 | | --- | | 假记载、误导性陈述或重大遗漏。 | 2025 年 3 月 28 日,祖名豆制品股份有限公司(以下简称"公司"或"祖名 股份")董事会收到独立董事丁志军先生的书面辞职报告。丁志军先生因在公司 连续担任独立董事已满 6 年,根据《上市公司独立董事管理办法》关于独立董事 连续任职年限的规定,申请辞去公司独立董事及在董事会各专门委员会相关职务, 辞职后不再担任公司任何职务。经确认,丁志军先生在任职期间与公司董事会和 经营管理层在公司重大决策和经营管理方面不存在分歧,亦无需要知会公司股东 及债权人的其他事项。截至本公告披露日,丁志军先生未持有公司股份,不存在 应当履行而未履行的承诺事项。 鉴于丁志军先生的辞职 ...